Toshio Kitawaki

13PUBLICATIONS
45CO-AUTHORS
Haematological tumoursPredictive and prognostic markersTumour immunologyCancer therapy (excl. chemotherapy and radiation therapy)Decision making
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Aug 03, 2026
Efficient discovery of an agonistic anti-OX40 nanobody by epitope-directed approach to address enrichment-driven epitope bias.

|Feb 14, 2026
Disease status at CAR T-cell infusion in relapsed or refractory large B-cell lymphoma: prognostic significance for real-world outcomes, irrespective of bridging therapy.

Yu Yagi, Yusuke Kanemasa, Hideki Goto

|Aug 11, 2025
Prolonged chimeric antigen receptor-T apheresis to infusion time is associated with inferior outcomes in diffuse large B-cell lymphoma.

Suguru Morimoto, Tomoyasu Jo, Toshio Kitawaki

|Jul 09, 2025
Consistent ex vivo cell proliferation during manufacturing predicts favourable outcomes post-CAR-T-cell therapy.

Tomoyasu Jo, Yasuyuki Arai, Tomoshige Shimizu

|Jan 06, 2025
Increased relative eosinophil counts portend neck oedema after chimeric antigen receptor-T therapy.

Naokazu Nakamura, Tomoyasu Jo, Yasuyuki Arai

|Dec 18, 2024
Fluctuation of physical function during chimeric antigen receptor T-cell therapy during rehabilitation intervention: Real-world data and risk factor analyses.

Ryota Hamada, Yasuyuki Arai, Toshio Kitawaki

Pageof 3

Frequent Collaborators

7 joint publications

Junya Kanda

7 joint publications

Yasuyuki Arai

5 joint publications

Akifumi Takaori-Kondo

5 joint publications

Tomoyasu Jo